Attached files
| file | filename |
|---|---|
| EX-99.1 - SLIDE PRESENTATION - ASSEMBLY BIOSCIENCES, INC. | v234574_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 12, 2011
|
VENTRUS BIOSCIENCES, INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Delaware
|
001-35005
|
20-8729264
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer ID Number)
|
|
99 Hudson Street, 5th Floor, New York, New York
|
10013 |
|
(Address of principal executive offices)
|
(Zip Code) |
|
Registrant’s telephone number, including area code
|
(646) 706-5208
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01.
|
Regulation FD Disclosure.
|
Ventrus Biosciences, Inc. is furnishing as an exhibit to this Form 8-K a PowerPoint presentation that is to be made available during the presentation by the Company’s Chief Executive Officer, Russell H. Ellison, at the Rodman & Renshaw 13th Annual Healthcare Conference being held in New York City on September 12, 2011.
The information furnished in this report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
(d)
|
Exhibits
|
|
|
Exhibit No.
|
Description
|
|
99.1
|
Slide presentation of September 12, 2011.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VENTRUS BIOSCIENCES, INC. | |||
|
Date: September 12, 2011
|
/s/ David J. Barrett | ||
| David J. Barrett, Chief Financial Officer | |||